CWG
VRTX icon

Cornerstone Wealth Group’s Vertex Pharmaceuticals VRTX Stock Holding History

Cornerstone Wealth Group’s Portfolio VRTX Stock Details VRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$296K Buy
596
+31
+5% +$13.7K 0.02% 358
2026
Q1 		$247K Buy
565
+102
+22% +$47.6K 0.02% 382
2025
Q4 		$210K Buy
+463
New +$200K 0.01% 367
2025
Q2 		– Sell
-420
Closed -$204K – 334
2025
Q1 		$204K Buy
+420
New +$196K 0.02% 278
2020
Q3 		– Sell
-3,833
Closed -$1.11M – 150
2020
Q2 		$1.11M Buy
+3,833
New +$1.04M 0.28% 74

Other funds holding VRTX

Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Cornerstone Wealth Group's VRTX Position: Q2 2026 in Review

Cornerstone Wealth Group increased its Vertex Pharmaceuticals (VRTX) stake by 5.5% in Q2 2026, buying an estimated $13.7K and bringing the position to 596 shares worth $296K. The position accounts for 0.02% of the portfolio, ranked #358.

Cornerstone Wealth Group first reported a position in VRTX in Q2 2020 and has held it in 5 quarters since. The position peaked at $1.11M in Q2 2020. 1,747 funds tracked by Wall St. Rank hold VRTX as of Q2 2026.

  • Cornerstone Wealth Group held 596 shares of Vertex Pharmaceuticals worth $296K as of Q2 2026.
  • Cornerstone Wealth Group bought 31 Vertex Pharmaceuticals shares in Q2 2026, an estimated $13.7K.
  • Vertex Pharmaceuticals made up 0.02% of Cornerstone Wealth Group's portfolio in Q2 2026, its #358 holding.
  • Cornerstone Wealth Group first reported a position in Vertex Pharmaceuticals in Q2 2020 and has held it in 5 quarters since.
  • Cornerstone Wealth Group's Vertex Pharmaceuticals position peaked at $1.11M in Q2 2020.
  • 1,747 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q2 2026.

Based on Cornerstone Wealth Group's 13F filing for Q2 2026, filed 27 Jul 2026.